Revolutionizing Wellness: The Mental Health Impact of GLP-1s and Weight Loss Video

The GLP-1 Shortage: What It Means and Why It Still Matters

Over the last few years, GLP-1 and GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Zepbound gained widespread traction for tackling obesity and supporting long-term weight loss efforts*. They decrease appetite, regulate blood sugar, and deliver consistent weight loss results for individuals struggling to manage their metabolic health. However, with the surge in demand comes […]

By divinoomdev

Noom Weight Loss Study: Promising Results Among Breast Cancer Survivors

Post-diagnosis weight gain is common in early-stage breast cancer and is associated with increased risk of recurrence and mortality. Intentional weight loss is difficult to maintain, and digital lifestyle interventions may provide a scalable approach to address this challenge. Navigating the path to better health can be challenging, but with the right tools and support, […]

By divinoomdev

From Weight Loss to Risk: Understanding GLP-1’s Impact on Eating Disorders

Weight loss medication abuse is not new. Diet pills, caffeine, laxatives, and others have been around for a long time, but with the emergence of GLP-1s, more reports of disordered eating have surfaced. While these drugs have helped millions of individuals reach their weight loss goals, many suffer side effects that ultimately lead them to discontinue use, resulting not only in money lost, but weight regain. In this post, we'll deep dive into the discussion around GLP-1s and eating disorders, to ensure that employers, providers and health plans have access to the right support for members on GLP-1s.

By divinoomdev